D-Plus Hemolytic Uremic Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About D-Plus Hemolytic Uremic Syndrome

What is the definition of D-Plus Hemolytic Uremic Syndrome?
D-plus (diarrhea positive) hemolytic uremic syndrome, also known as STEC hemolytic uremic syndrome, is a rare disease that affects children between one and ten years old which is characterized by low levels of red blood cells (hemolytic anemia), low platelets (thrombocytopenia), and an inability of the kidneys to process waste products from the blood (uremia). D-plus hemolytic uremic syndrome develops after certain bacterial infections, such as Escherichia. coli (E. coli) that cause diarrhea.
What are the symptoms of D-Plus Hemolytic Uremic Syndrome?
Symptoms of D-plus hemolytic uremic syndrome can be mild or severe and usually appear after an illness that is characterized by fever, abdominal cramps and pain, nausea, vomiting, and bloody diarrhea (gastroenteritis). Symptoms of D-plus hemolytic uremic syndrome may include paleness, irritability, weakness, reduced urinary output or no urine, lethargy, acute kidney injury, chronic kidney disease, protein in the urine, unexplained bruising, nosebleeds, high blood pressure, gallstones, neurological deficits, confusion, partial paralysis, seizures, coma, pancreatitis, and diabetes mellitus.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for D-Plus Hemolytic Uremic Syndrome?
Treatment for D-minus hemolytic uremic syndrome may include intravenous fluid and nutrition replacement, kidney or peritoneal dialysis, blood transfusion, vasodilators, medications, such as eculizumab and ultomiris (favulizumab-cwyz), plasma exchange (plasmapheresis), immunosuppressive therapy, or kidney transplantation.
Who are the top D-Plus Hemolytic Uremic Syndrome Local Doctors?
Elite in D-Plus Hemolytic Uremic Syndrome
Hematology | Oncology
Elite in D-Plus Hemolytic Uremic Syndrome
Hematology | Oncology
Referral may be required

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, 
Baltimore, MD 
Languages Spoken:
English
Accepting New Patients

Robert Brodsky is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.

Elite in D-Plus Hemolytic Uremic Syndrome
Elite in D-Plus Hemolytic Uremic Syndrome
Referral may be required
Milan, IT 

Gianluigi Ardissino practices practicing medicine in Milan, Italy. Mr. Ardissino is rated as an Elite expert by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in D-Plus Hemolytic Uremic Syndrome
Elite in D-Plus Hemolytic Uremic Syndrome
Referral may be required

Office

181 Taylor Ave Fl 13, 
Columbus, OH 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Spero Cataland is a Hematologist practicing medicine in Columbus, Ohio. Dr. Cataland is rated as an Elite provider by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Splenectomy. Dr. Cataland is currently accepting new patients.

What are the latest D-Plus Hemolytic Uremic Syndrome Clinical Trials?
A Non-interventional Study Evaluating Ravulizumab Treatment Outcomes in Polish Patients With Atypical Hemolytic Uremic Syndrome

Summary: This multicenter, observational cohort study uses retrospective collection of past medical history and prospective follow-up to capture longitudinal data on the management and clinical outcomes of patients with atypical hemolytic uremic syndrome (aHUS) treated with ravulizumab as part of routine clinical practice under Poland's National Drug Program (NDP).

Match to trials
Find the right clinical trials for you in under a minute
Get started